Abstract |
Recent decades have seen a significant increase in the incidence of diabetes mellitus. The number of individuals with diabetes is projected to reach 300 million by the year 2025. Diabetes is a leading cause of blindness, renal failure, lower limb amputation, and an independent risk factor for atherosclerotic cardiovascular disease (CVD)--a leading cause of death in Western society. Understanding the molecular and cellular mechanisms by which diabetes mellitus promotes atherosclerosis is essential to developing methods to treat and prevent diabetes-associated CVD. This review summarizes our current knowledge of the mechanisms by which diabetes may promote atherogenesis and specifically focuses on a novel pathway linking these 2 conditions. We hypothesize that the accumulation of intracellular glucosamine observed in conditions of chronic hyperglycaemia may promote atherogenesis via a mechanism involving dysregulated protein folding, activation of endoplasmic reticulum (ER) stress, and increased glycogen synthase kinase (GSK)-3 activity. The identification of this novel mechanism provides a promising hypothesis and multiple new targets for potential therapeutic intervention in the treatment of diabetes mellitus and accelerated atherosclerosis.
|
Authors | Lindsie A Robertson, Anna J Kim, Geoff H Werstuck |
Journal | Canadian journal of physiology and pharmacology
(Can J Physiol Pharmacol)
Vol. 84
Issue 1
Pg. 39-48
(Jan 2006)
ISSN: 0008-4212 [Print] Canada |
PMID | 16845889
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Protein Kinase Inhibitors
- Glycogen Synthase Kinase 3
|
Topics |
- Animals
- Atherosclerosis
(metabolism)
- Diabetes Complications
(metabolism)
- Diabetes Mellitus
(metabolism)
- Endoplasmic Reticulum
(metabolism)
- Glycogen Synthase Kinase 3
(antagonists & inhibitors, metabolism)
- Humans
- Hyperglycemia
(complications, metabolism)
- Protein Kinase Inhibitors
(pharmacology)
|